27Jun
Navigating ANVISA’s Cleaning Validation Requirements — with a Spotlight on Solubility Criteria —
If you’re preparing for an ANVISA inspection—or simply raising the bar on
26Jun
FDA Updates NDSRI Implementation Timelines – What You Need to Know
On June 23, 2025, FDA quietly revised its “CDER Nitrosamine Impurity Acceptable
18Jun
Streamlining Generic Drug Approvals: A Closer Look at the New ANDA Guidance
In June 2025, the U.S. Department of Health and Human Services and
